Navigation Links
Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen

BARCELONA, Spain, December 14, 2011 /PRNewswire/ --

The Contract Research Organization Kymos Pharma Services -specialised in analysis for the pharmaceutical, fine chemicals, biotechnological, veterinary, cosmetic and nutraceuticals sectors- has signed an agreement with the French multinational group Ipsen to take in a team of eight scientists from Ipsen R&D Centre in Sant Feliu de Llobregat (Barcelona).

For Kymos -with headquarters in Barcelona Science Park (PCB) and celebrating its 10th anniversary this year- this agreement allows the creation of an innovative area of R&D services in the field of bio molecules and biosimilars. Kymos will carry out this activity in a new immunology laboratory that will be opened in the PCB in early January 2012, conducting regulatory development projects for biotech companies.

"This new alliance consolidates the company's growth plan. The agreement also speeds up our international expansion plans, thus our company will be the only Spanish CRO and one of the few European ones that will be able to offer comprehensive services for biotech companies according to Good Laboratory Practices and Good Manufacturing Practices," says Joan Puig, strategic general manager of Kymos.  

About KymosPharma Services

Kymos Pharma Services is a CRO located in the PCB that was created in 2001 by a group of professionals with over 10 years of experience in R&D of pharmaceutical companies. The company is focused on comprehensive analytical development studies for pharmaceutical and related sectors, as well as on bioanalysis of preclinical and clinical studies of small molecules. At present, its financial turnover exceeds 2.5 million Euros, with a staff of 35 professionals and direct activities in Portugal and Italy. The company has over 80 clients, including the main Spanish pharmaceutical companies and clients from several countries such as France, Great Britain and Switzerland.

About Ipsen

Ipsen is a French biotechnology multinational group with sales of 1,100 million Euros that is listed on the Euronext stockmarket of Paris. It has 4,500 employees worldwide with offices in 50 countries and products sold in over 100.  As a leader in the biotech sector, Ipsen assigns 20% of its profits to R+D focused on the development of peptides and proteins in the therapeutic areas of neurology, endocrinology, oncology and haematology.  


SOURCE Kymos Pharma Services
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
2. IPC The Hospitalist Company, Inc. to Report Third Quarter 2009 Results
3. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
4. IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference
5. Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities New Ideas for the New Year Conference on Thursday, January 14th
6. RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parker™ Surgical Blades and Scalpels Business
7. QuantaLife, a New Life Science Tool Company, Receives NIH Grant
8. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
9. IPC The Hospitalist Company, Inc. to Report Fourth Quarter 2010 Results
10. Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company
11. LaVoie Group Wins Gold Mercury Award For Medical Device Company, Alphatec Spine
Post Your Comments:
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):